WASHINGTON (AP) - A panel of U.S. respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease.
A majority of Food and Drug Administration panelists voted that the Breo Ellipta inhaler is safe and effective for long-term use and to control flare ups in patients with chronic obstructive pulmonary disorder.
The FDA is not required to follow the group's recommendation, though it often does.
The ailment, often called smoker's cough, can cause a number of breathing problems, including chronic bronchitis and emphysema.
Breo is a combination of two respiratory drugs that help to open lung airways and reduce swelling. The combination drug is designed to be used with the Ellipta inhaler device.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Right on cue, Thursday’s early winter storm dumped snow and ice on the Wabash Valley but county highway crews were a step ahead of the weather’s arrival pre-treating the 897 miles of pavement in the county.
A fire has engulfed the First Prairie Creek Church in Vigo County.
A four car accident in eastern Vigo County leaves one person dead.
Workers at a new eatery in Terre Haute are preparing to open.
Otter Creek Township is on its way to getting a new fire station.
Knox County Commissioner Don Halter is ahead of the game when it comes to winter weather preparedness. But the man-power may have a hard time running full throttle. The Knox County highway budget took big cuts in 2013.